Premium Brand STROMUSC Methenolone Enanthate 100mg/ml For Bodybuilding CAS:303-42-4

   What It Is

    Methenolone enanthate is the injectable ester form of methenolone, a dihydrotestosterone (DHT)-derived anabolic-androgenic steroid first synthesized in the early 1960s. It is most widely recognized under the trade name Primobolan Depot, originally manufactured by Schering AG. The compound is structurally defined by a 1-methyl modification that prevents aromatization and confers resistance to 5α-reduction - a structural nuance that accounts for virtually all of its practical properties.

    A "premium brand" version at 100mg/ml delivers the same active molecule but in a formulation distinguished by several variables: the purity of the raw methenolone enanthate powder, the carrier oil selected for injection, the sterility of the manufacturing process, and the accuracy of the concentration stated on the label. These factors matter more than most users acknowledge. Methenolone enanthate is among the most frequently counterfeited compounds in the underground market, and a premium brand differentiates itself through verifiable purity - often confirmed by third-party HPLC testing - and a carrier oil chosen for smooth injection rather than cost minimization.

    The defining pharmacological features of methenolone enanthate are best understood as a series of structural consequences. First, because it is a DHT derivative, it does not aromatize. There is no conversion to estrogen, which means the classic estrogenic side effects - water retention, gynecomastia risk, blood pressure elevation from estradiol - are not driven by this compound. Second, it is already 5α-reduced, which means 5α-reductase inhibitors such as finasteride have no meaningful effect on it. Third, it is not 17α-alkylated, so hepatic strain from the oral bioavailability mechanism is absent.

    The anabolic-to-androgenic ratio is conventionally cited at 88:44-57, with testosterone set at 100:100. This ratio indicates a compound that is moderately anabolic and comparatively weakly androgenic. The practical implication is that methenolone enanthate produces muscle growth without the aggressive androgenic signaling that drives prostate stimulation, scalp hair loss in genetically predisposed users, or the pronounced central nervous system activation associated with stronger androgens. It also stimulates erythropoiesis - red blood cell production - which can support endurance and oxygen delivery to working muscle tissue.

    The compound activates the androgen receptor and promotes protein synthesis and nitrogen retention. It also exhibits anti-catabolic activity by inhibiting glucocorticoid action, which reduces muscle protein breakdown during periods of physiological stress or caloric deficit.

    The bodybuilding applications of methenolone enanthate are narrower than those of testosterone or nandrolone, and this specificity is precisely why it occupies a distinct niche. It is not a mass-building compound in the conventional sense. Users do not turn to it for rapid size gains or dramatic strength increases. They use it for what it preserves and what it reveals.

    Lean tissue preservation during caloric deficit. This is the single most cited application. When an athlete is in a sustained caloric deficit, the body mobilizes both fat and muscle for energy. Methenolone enanthate's anti-catabolic action attenuates muscle protein breakdown, allowing the user to retain lean mass while shedding fat. The result is not a transformed physique in the way a bulking cycle would produce, but a physique that appears harder, fuller, and more defined at a lower body fat percentage.

    Quality muscle gains without water retention. The absence of aromatization means no subcutaneous water retention. Any muscle added on a methenolone cycle tends to look denser and more "dry" than muscle added on an aromatizing compound. For physique competitors in the final stages of contest preparation, this is a significant practical advantage: the visual difference between a water-retaining compound and a non-aromatizing one at low body fat is substantial.

    Stacking compatibility. Methenolone enanthate is notable for how little it disrupts other compounds in a stack. It does not compete aggressively for the androgen receptor in the way stronger androgens do, and it does not introduce estrogenic or progestogenic activity that would complicate cycle management. It is commonly stacked with testosterone at a low-to-moderate dose, with the testosterone providing the anabolic foundation and the methenolone contributing to the quality and preservation of the resulting tissue.

    Female use. Because methenolone is only weakly androgenic and does not aromatize, it is one of the few injectable anabolic steroids considered viable for female users at low doses. Virilization risk is not eliminated - it is reduced but present - and doses are typically one-quarter to one-half of the male range, with shorter cycles.

    The dosage range for injectable methenolone enanthate in male bodybuilding contexts is well-documented and consistently cited across sources.

    Beginner/entry-level: 300–400mg per week, split into two injections.

    Intermediate: 400–600mg per week. This is the most commonly used range for experienced users running a cutting or recomposition cycle.

    Advanced: 500–700mg per week. The compound is dose-sensitive; gains below approximately 500mg per week are often described as marginal, and the cost per milligram means that lower doses are frequently considered wasteful rather than conservative.

    For female users, the dosage range is dramatically lower: 50–100mg per week is the commonly cited ceiling, with 50mg per week being a conservative starting point.

    The 100mg/ml concentration is a practical format. It allows a user running 400mg per week to draw 2ml per injection twice weekly, or a user running 300mg per week to draw 1.5ml twice weekly. Higher-concentration formulations (200mg/ml) exist but are associated with more injection-site discomfort due to the higher solvent content required to keep the compound in solution.

    A standard methenolone enanthate cycle runs for 10–12 weeks, though some users extend to 16 weeks when using it as the primary compound in a longer preparation phase. The cycle structure depends on whether methenolone is the primary anabolic agent or an ancillary one.

    When methenolone is the primary compound, it is typically stacked with a low dose of testosterone - often a therapeutic replacement-level dose of 100–150mg per week - to maintain baseline physiological function and sexual health. The methenolone provides the quality tissue effects; the testosterone prevents the libido and mood disruptions that can accompany a fully suppressed endogenous system.

    When methenolone is used as an ancillary compound in a larger stack, it is often added during the final 6–8 weeks of a cycle to "harden" the physique and preserve muscle during the transition from a surplus to a deficit. Its lack of interference with other compounds makes this addition relatively straightforward.

    Injection frequency is determined by the enanthate ester. The elimination half-life is approximately 10.5 days, but stable blood levels are best maintained with twice-weekly injections rather than once-weekly, despite the long half-life. Injecting 2ml twice weekly (at 100mg/ml, that is 400mg per week) is a common practical schedule.

    The elimination half-life of methenolone enanthate by intramuscular injection is reported at approximately 10.5 days. This is the pharmacokinetic parameter that governs injection frequency, blood-level stability, and - critically - the timing of post-cycle therapy.

    A 10.5-day half-life means that after the final injection, the compound remains above meaningful threshold concentrations for approximately three to four weeks. Using the standard rule that a compound requires roughly five half-lives to clear the system, the practical clearance window is 50–53 days. This long tail is the reason PCT timing is not calculated from the last injection but from the point at which the slowest ester in the cycle has sufficiently cleared.

    PCT is not optional. Methenolone enanthate suppresses endogenous testosterone production, and while the suppression is moderate compared to stronger androgens, it is real and requires a structured recovery phase.

    Timing. PCT should begin approximately 14–18 days after the final methenolone enanthate injection. If the cycle included a testosterone ester with a longer half-life - such as testosterone cypionate - the PCT start date must be synchronized to the longer ester, not the methenolone. The slowest compound determines the clearance window.

    Protocol. A standard SERM-based PCT for a methenolone enanthate cycle uses either nolvadex (tamoxifen) or clomiphene citrate, or a combination of both. A representative protocol:

    ●Nolvadex: 40mg daily for the first two weeks, reduced to 20mg daily for the following two weeks.

    ●Clomiphene: 50mg daily for four weeks, sometimes tapered to 25mg in the final two weeks.

    Some users combine both at reduced doses - for example, nolvadex 20mg and clomiphene 25mg daily - to stimulate luteinizing hormone and follicle-stimulating hormone through two distinct pathways.

    Ancillary considerations. Because methenolone does not aromatize, aromatase inhibitors are not needed during the cycle. There is no estrogen to manage. This simplifies on-cycle management considerably and is one of the compound's practical advantages. Lipid support - fish oil, citrus bergamot, cardio - is advisable given the adverse lipid shifts associated with anabolic steroid use generally, even with a mild compound. Post-cycle bloodwork should include total testosterone, LH, FSH, estradiol, lipids, and a complete metabolic panel to confirm recovery.

Brand	STROMUSC
Trade names	Metenolone enanthate,Nibal Injection,Primobolan Depot Metenolone 17β-enanthate; NSC-64967; SH-601; SQ-16374;
CAS	303-42-4
Molar mass	414.630
Formula	C27H42O3
Purity	Above 98%
Capacity/Bottle	100mg/ml

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-15871669785

   

                                  

 

    The distinction between a premium-brand methenolone enanthate and a generic or counterfeit product is not marketing language. It is a matter of what is actually in the vial. Methenolone enanthate raw powder is expensive, and the underground market contains products that are underdosed, mislabeled, or entirely substituted with cheaper compounds. A premium brand that provides third-party HPLC verification, uses pharmaceutical-grade carrier oil (typically MCT, grapeseed, or sesame), and maintains GMP-compliant sterile manufacturing offers a materially different product from an unverified source. For a compound whose effects are dose-dependent and subtle, this difference is not incidental - it is the difference between a cycle that produces the expected tissue-quality outcomes and one that produces nothing but injection discomfort and wasted money.

Hot Tags: premium brand stromusc methenolone enanthate 100mg/ml for bodybuilding cas:303-42-4, China premium brand stromusc methenolone enanthate 100mg/ml for bodybuilding cas:303-42-4 manufacturers, suppliers, factory